Key result
QRT-PCR evaluation revealed different transcriptional activities of the KCNH2 gene in LQTS2 patients compared to healthy controls, but no differences for the KCNQ1 gene.
Why the study?
Can QRT-PCR of KCNQ1 and KCNH2 gene expression differentiate patients with LQTS1 and LQTS2 from healthy controls?
Case-Control
Can QRT-PCR of KCNQ1 and KCNH2 gene expression differentiate patients with LQTS1 and LQTS2 from healthy controls?
QRT-PCR of KCNH2 gene expression may serve as a complementary diagnostic tool for LQTS2, but it is not effective for LQTS1 and cannot be used as a sole diagnostic criterion.
KCNH2 qRT-PCR differences may support further LQTS2 evaluation; leaves open diagnostic utility without prospective validation.
Congenital long-QT syndrome is a genetic disorder associated with abnormalities in the function and/or structure of cardiac ion channels. Up to the present, 13 types of the disease have been described (LQTS1-13) which result from the fact that 13 genes of which mutations can have an influence on the occurrence of the disease have been identified. Characteristic symptoms of the disease include the changes in the ECG (QT interval prolonged above 450 ms), "torsade de pointes," fainting, and even sudden cardiac death. The present study has been focused on two types of the disease, namely, LQTS1 and LQTS2. The examination of two appropriate genes expression (KCNQ1; KCNH2) at the transcription level by QRT-PCR in a group of LQTS patients and a healthy control group showed different transcriptional activities of KCNH2 gene in LQTS2 patients compared to the control individuals. KCNQ1 gene expression study did not reveal such differences between both groups. The results indicate that QRT-PCR may serve as a complimentary method to the identification of molecular alterations in genetic determinants of LQTS2 only, but it cannot be used as a sole diagnostic criterion.
No takes yet. Share an insight, caveat, or question.
Moric‐Janiszewska et al. (2013) conducted a case-control in Long-QT Syndrome (LQTS1 and LQTS2). QRT-PCR for KCNQ1 and KCNH2 gene expression vs. Healthy control group was evaluated on Transcriptional activities of KCNQ1 and KCNH2 genes. QRT-PCR evaluation revealed different transcriptional activities of the KCNH2 gene in LQTS2 patients compared to healthy controls, but no differences for the KCNQ1 gene.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: